CervoMed (NASDAQ:CRVO) Given Buy Rating at D. Boral Capital
D. Boral Capital reaffirmed their buy rating on shares of CervoMed (NASDAQ:CRVO – Free Report) in a research report released on Monday,Benzinga reports. The brokerage currently has a $10.00 price target on the stock. Other research analysts have also recently issued research reports about the stock. HC Wainwright cut shares of CervoMed from a “buy” […]
D. Boral Capital reaffirmed their buy rating on shares of CervoMed (NASDAQ:CRVO – Free Report) in a research report released on Monday,Benzinga reports. The brokerage currently has a $10.00 price target on the stock. Other research analysts have also recently issued research reports about the stock. HC Wainwright cut shares of CervoMed from a “buy” […]
